Navigation Links
MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting
Date:5/4/2013

GAITHERSBURG, Md., May 4, 2013 /PRNewswire/ -- MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E. Washington Convention Center in Washington DC, May 4-7, 2013.  These abstracts advance the body of existing data and knowledge around influenza and respiratory syncytial virus (RSV) prevention, highlighting MedImmune's continued commitment to patient health.

MedImmune posters to be presented at PAS regarding influenza include:

  • Efficacy of Live Attenuated Influenza Vaccine Against Moderate to Severe Versus Mild Influenza Illness in Children. Ambrose CS, Wu X, Belshe RB. Platform Presentation Session: May 4, 2013, 9:45 AM, Session: Section 115- Infectious Diseases, Vaccines & Infections 

  • Serum HAI Antibody Response to LAIV in 2 to 49 Year Olds.Coelingh K, Wu X, Mallory R, Ambrose CS. Poster Session: May 4, 2013, 1:00 PM – 4:00 PM; Exhibit Hall D/E; Board: 493

MedImmune posters to be presented at PAS regarding RSV include:

  • Burden of and Risk Factors for Medically Attended RSV Illness in 32−35 w/GA Infants Not Receiving RSV Prophylaxis. Groothuis J, Wu X, Makari D, Ambrose CS.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.4. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 4

  • Risk for Medically Attended RSV Illness in 32−34 Weeks vs. 35 Weeks Gestational Age Preterm Infants Not Receiving Palivizumab.  Groothuis J, Wu X, Makari D, Ambrose CS.  Publication Number 1500.3.  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm. Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 3 

  • Respiratory Syncytial Virus Surveillance, 2007–2012: Results from RSVAlert®, a U.S. National Hospital-Based Surveillance Program. Boron M, Kumar V, McGuiness CB, Saunders B, Rabon-Stith K .  Poster Session: May 4, 2013, 1:00 pm− 4:00 pm, Publication Number: 1500.7, Session: 1500 – Epidemiology, Exhibit Hall D/E, Board: 7

  • Impact of Partial Prophylaxis with Palivizumab on RSV Hospitalizations among Commercially-Insured High-Risk Preterm Infants. Ryan K, Stewart D, Frogel M, Becker L, Pinsky B. Poster Session : May 5, 2013, 4:15 pm− 7:30 pm. Publication Number: 2915.209. Session: 2915 − Infectious Diseases, Exhibit Hall D/E, Board: 209

  • Pharmacokinetic (PK) Profile of Palivizumab (Pali) in Premature Infants. La Via WV, Makari D, Yu X, Robbie GJ. Poster Session: May 7, 2013, 10:00 am− 2:00 pm. Publication Number: 4514.228.  Session: 4514 − Neonatal Infectious Diseases / Immunology, Exhibit Hall D/E, Board: 228

Additional information about the 2013 PAS conference can be found at
http://www.pas-meeting.org/2013DC/default.asp 

About MedImmune 
MedImmune is the worldwide biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines.  MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines.  MedImmune has approximately 2,500 employees globally, with its headquarters located in Gaithersburg, Md., one of AstraZeneca's three global R&D centers.  For more information, please visit www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
2. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
3. Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
4. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
5. Zimmer Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
6. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
7. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
8. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
9. XBiotech to Present at UBS Global Healthcare Conference
10. Leonhardt Ventures to Present Technology Showcase @ Heart Rhythm 2013
11. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... highlights the necessity of health literacy within the technology advancement of diagnostic imaging. According to ... a majority of oncology patients undergo imaging screenings without understanding the nuanced risks associated ... ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... May 27, 2016 Hutchison ... company focused on the highly lucrative global oncology ... pipeline of potential first-in-class or best-in-class tyrosine kinase ... development with strategic partners. HCM,s profitable Chinese healthcare ... market. We expect progress of the mid-to-late-stage pipeline ...
(Date:5/27/2016)... NEW YORK , May 27, 2016 ... with biotechs, drug manufacturers, health insurance companies all falling ... very small healthcare companies. While not often talked about, ... The United States is by ... the world. Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... June 01, 2016 , ... ... smoking: links and risks ”. , As corresponding author Professor Luigi Naldi says ... between smoking habits and psoriasis. Smoking influences the onset and the severity of ...
(Date:5/31/2016)... GA (PRWEB) , ... May 31, 2016 , ... ... Contact Center Solutions , today announced it has been included by Gartner, Inc. ... report mentions a wide range of Contact Center Infrastructure technologies, some of which ...
(Date:5/31/2016)... ... May 31, 2016 , ... When ... he knew it was something that contractors should have at their disposal on ... gets,” says Butch, CertainTeed’s Director of Contractor Programs. , As a result, ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of ... their laboratories as well. However, laboratories have different challenges compared to manufacturing environments. ... operations in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . ...
(Date:5/31/2016)... ... ... Spectrum Aquatics has launched a brand new ADA pool lift, the Motion Trek ... in mind. , “Over the last two years our key customers and designers plus ... is a necessary requirement for certain facilities with specific needs,” said Nabil Khaled, Spectrum ...
Breaking Medicine News(10 mins):